20 10- School of Pharmacy, Jiangsu University to date

2008-20 10 Assistant Research Fellow, University of Wisconsin-Madison, USA. (Engaged in the synthesis and screening of anticancer drugs, glycosylation of natural products catalyzed by enzymes, and sugar chemistry research)

From 2006 to 2008, he was a postdoctoral fellow at CMLD Drug Research and Development Center, University of Kansas. (Engaged in the design, synthesis and Qualcomm screening of medicinal compounds)

In 2005, he was a postdoctoral researcher (organic synthesis methodology) in the Department of Chemistry, Mississippi State University, USA.

1999-2004 Mississippi state university, USA, obtained a doctorate in organic chemistry (and completed all chemical theory courses and engineering mathematics courses required for doctoral graduation in chemical engineering department).

1995- 1999 Work of Terephthalic Acid Plant in Yizheng Chemical Fiber Company of China Petrochemical Company.

199 1- 1995 worked in the No.1 Chemical Plant and Aromatics Plant of Liaoyang Chemical Fiber Company of China Petroleum.

1988- 199 1 Department of Chemistry, School of Chemical Engineering, Dalian University of Technology, Master of Applied Chemistry.

1984- 1988 Department of Chemical Engineering, School of Chemical Engineering, Dalian University of Technology.

Scientific research status

I have worked in several petrochemical plants for many years and spent a lot of time in the front line. I have rich experience in continuous catalytic reforming and regeneration (UOP process), aromatics extraction, disproportionation and isomerization, xylene separation (rotary adsorption molecular sieve separation), pyrolysis gasoline hydrogenation, propane/butane hydrogen production, PTA terephthalic acid plant (BP-AMOCO process) start-up, shutdown, normal operation and accident handling. In addition to the process, I also have a good understanding of various catalysts, automatic instruments, automatic operation and chain control.

During the period of US 1 1, a number of projects funded by the US Department of Health (NIH) and the US Natural Science Foundation (NIH AI522 18, NIH P50 GM069663, NIH P4 1 GM076302 and NSF, EPS 0/) were implemented and completed.

Obtained four invention patents, helped domestic pharmaceutical companies to formulate the synthesis process and quality standards of anticancer drugs, and helped domestic chemical companies to complete two research projects, such as C9 aromatic hydrocarbon catalyst development and process route design. And published (and will soon be published) many high-impact factor research papers in international first-class professional journals.